Entos Pharmaceuticals (Entos) Announces Participation in the 2025 Bloom Burton & Co. Healthcare Investor Conference
Edmonton, Alberta--(Newsfile Corp. - May 1, 2025) - Entos Pharmaceuticals (Entos), a clinical-stage genetic medicines company headquartered in Edmonton, Canada, with offices in London, UK, and San Diego, USA, will be participating in the 2025 Bloom Burton & Co. Healthcare Investor Conference, which will take place on May 5 and...
Technology, Biotechnology, Investment Banking, Health
2025-05-01 8:30 AM EDT | Bloom Burton & Co. Inc.
BioHarvest Sciences to Host First Quarter 2025 Earnings Call on May 15 at 4:30 p.m. Eastern Time
Rehovot, Israel--(Newsfile Corp. - May 1, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that it will release financial results for the first quarter ended March 31, 2025 after market close on Thursday, May...
Biotechnology, Pharmaceuticals, Health
2025-05-01 8:30 AM EDT | BioHarvest Sciences Inc.
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Marlborough, Massachusetts--(Newsfile Corp. - May 1, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present an update...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-01 7:45 AM EDT | Phio Pharmaceuticals Corp.
Glow Lifetech Reports 2024 Financials, Delivering Record Q4 Results with 46% Quarterly Revenue Growth and Strengthened Balance Sheet
Toronto, Ontario--(Newsfile Corp. - May 1, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to report its financial results for the fourth quarter and the fiscal year ended December 31, 2024 ("Q4 2024" and "FY 2024"). In Q4 2024, Glow...
2025-05-01 7:30 AM EDT | Glow Lifetech Corp.
Psyence BioMed Announces Effective Date for 1-for-7.97 Reverse Stock Split
New York, New York--(Newsfile Corp. - May 1, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced the effective date of its 1-for-7.97 share consolidation (reverse stock split) of the Company's issued and outstanding common shares. At a Special Meeting of Stockholders held on April...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-05-01 7:30 AM EDT | Psyence Biomedical Ltd.